Publication | Open Access
CS1, a Potential New Therapeutic Antibody Target for the Treatment of Multiple Myeloma
555
Citations
43
References
2008
Year
These results suggest that HuLuc63 eliminates myeloma cells, at least in part, via NK-mediated ADCC and shows the therapeutic potential of targeting CS1 with HuLuc63 for the treatment of multiple myeloma.
| Year | Citations | |
|---|---|---|
Page 1
Page 1